Terns Pharmaceuticals (TERN) Q1 2025 Earnings
TERN·Reported May 8, 2025·Before market open
Diluted EPS came in at $-0.26 (+13.3% YoY), beat the $-0.29 consensus by $0.03.
Diluted EPS
$-0.26beat by $0.03
Consensus: $-0.29
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Terns Pharmaceuticals's Q1 2025 earnings report.
Terns Pharmaceuticals (TERN) reported Q1 2025 earnings on May 8, 2025 before market open.
Terns Pharmaceuticals reported diluted EPS of $-0.26 for Q1 2025.
EPS beat the consensus estimate of $-0.29 by $0.03.
Compared to the same quarter a year prior, diluted EPS grew 13.3% from $-0.30.
You can read the 10-Q periodic report (0000950170-25-067003) directly on SEC EDGAR. The filing index links above go to sec.gov.